<bill session="115" type="s" number="2514" updated="2019-04-18T16:41:59Z">
  <state datetime="2018-03-07">REFERRED</state>
  <status>
    <introduced datetime="2018-03-07"/>
  </status>
  <introduced datetime="2018-03-07"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title 35, United States Code, to provide that a patent owner may not assert sovereign immunity as a defense in certain actions before the United States Patent and Trademark Office, and for other purposes.</title>
    <title type="short" as="introduced">PACED Act</title>
    <title type="short" as="introduced">PACED Act</title>
    <title type="short" as="introduced">Preserving Access to Cost Effective Drugs Act</title>
    <title type="short" as="introduced">Preserving Access to Cost Effective Drugs Act</title>
    <title type="display">PACED Act</title>
  </titles>
  <sponsor bioguide_id="C001095"/>
  <cosponsors>
    <cosponsor bioguide_id="E000295" joined="2018-03-07"/>
    <cosponsor bioguide_id="M001170" joined="2018-03-07"/>
    <cosponsor bioguide_id="P000612" joined="2018-03-07"/>
    <cosponsor bioguide_id="T000461" joined="2018-03-07"/>
  </cosponsors>
  <actions>
    <action datetime="2018-03-07">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-03-07" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSJU" name="Senate Judiciary" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Commerce"/>
    <term name="Civil actions and liability"/>
    <term name="Competitiveness, trade promotion, trade deficits"/>
    <term name="Federal-Indian relations"/>
    <term name="Government liability"/>
    <term name="Intellectual property"/>
    <term name="Jurisdiction and venue"/>
    <term name="Sovereignty, recognition, national governance and status"/>
  </subjects>
  <amendments/>
  <summary date="2018-03-07T05:00:00Z" status="Introduced in Senate">Preserving Access to Cost Effective Drugs Act or the PACED Act

This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings&#160;before the International Trade Commission.

Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.</summary>
  <committee-reports/>
</bill>
